1. Home
  2. ALCO vs HELP Comparison

ALCO vs HELP Comparison

Compare ALCO & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

N/A

Current Price

$40.61

Market Cap

293.7M

Sector

N/A

ML Signal

N/A

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.52

Market Cap

281.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALCO
HELP
Founded
1960
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.7M
281.4M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ALCO
HELP
Price
$40.61
$4.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$44.00
$95.00
AVG Volume (30 Days)
26.6K
1.1M
Earning Date
05-12-2026
07-01-2026
Dividend Yield
0.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.61
$4.41
52 Week High
$43.20
$8.55

Technical Indicators

Market Signals
Indicator
ALCO
HELP
Relative Strength Index (RSI) 55.54 35.50
Support Level $39.99 $4.47
Resistance Level $42.58 $4.95
Average True Range (ATR) 1.30 0.34
MACD 0.20 -0.03
Stochastic Oscillator 71.10 7.19

Price Performance

Historical Comparison
ALCO
HELP

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: